Table 2 |
|||
|
Pulmonary MPO, cytokine and chemokine levels in pneumococcal pneumonia after antibiotic treatment |
|||
|
48 hours |
|||
|
|
|||
|
WT n = 8 |
Heterozygous n = 8 |
Homozygous n = 7 |
|
|
|
|||
|
MPO (ng/mL) |
23 (20-24) |
19 (17-21) |
19 (14-21) |
|
TNF-α (ng/mL) |
0.8 (0.4-1.1) |
0.6 (0.3-0.9) |
0.6 (0.2-0.9) |
|
IL-6 (ng/mL) |
0.3 (0.2-0.4) |
0.3 (0.2-0.5) |
0.3 (0.2-0.6) |
|
MCP-1 (ng/mL) |
7.1 (5.5-9.4) |
8.0 (5.3-10) |
7.1 (5.6-10) |
|
KC (ng/mL) |
1.4 (1.1-1.7) |
1.1 (0.9-1.3) |
1.2 (0.9-1.4) |
|
|
|||
|
Data are medians (interquartile ranges). No statistical differences between the groups at either time point. KC, keratinocyte-derived chemokine; MCP-1, monocyte chemotactic protein; MPO, myeloperoxidase; WT, wild type. |
|||
|
Schouten et al. Critical Care 2010 14:R145 doi:10.1186/cc9213 |
|||